PharmaLundensis

0,10 SEK

+27,46%

Mindre end 1K følgere

PHAL

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

+27,46 %
-58,27 %
-60,19 %
-57,93 %
-79,13 %
-81,91 %
-81,90 %
-87,40 %
-96,84 %

PharmaLundensis is a research company. The company's main focus is on the treatment of serious lung diseases. Diseases that the company specializes in include chronic obstructive pulmonary disease (COPD), chronic bronchitis, and influenza-induced pulmonary failure. In addition to its main business, technical systems for handling drug emissions are developed. PharmaLundensis has its headquarters in Lund.

Læs mere
Markedsværdi
6,65 mio. SEK
Aktieomsætning
13,74 t SEK
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin

Omsætning

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
21.5
2026

Delårsrapport Q1'26

20.8
2026

Delårsrapport Q2'26

19.11
2026

Delårsrapport Q3'26